Lei Ni
- Molecular Biology top 10%
- Cancer Research top 5%
- Immunology top 10%
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Topics
- MicroRNA in disease regulation (18 papers)RNA modifications and cancer (10 papers)Cancer-related molecular mechanisms research (8 papers)
- Cited by
- Cancer ResearchImmunologyHepatology
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Lei Ni
99 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 143
- Molecular Biology 782
- Cancer Research 485
- Immunology 266
- Oncology 249
- Pulmonary and Respiratory Medicine 190
Countries citing papers authored by Lei Ni
This map shows the geographic impact of Lei Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Ni more than expected).
Fields of papers citing papers by Lei Ni
This network shows the impact of papers produced by Lei Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Ni. The network helps show where Lei Ni may publish in the future.
Co-authorship network of co-authors of Lei Ni
This figure shows the co-authorship network connecting the top 25 collaborators of Lei Ni. A scholar is included among the top collaborators of Lei Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Ni. Lei Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 6 | |
| 6 | 2 | |
| 7 | 8 | |
| 8 | 4 | |
| 9 | 15 | |
| 10 | 19 | |
| 11 | 1 | |
| 12 | 5 | |
| 13 | 11 | |
| 14 | 3 | |
| 15 | 58 | |
| 16 | 14 | |
| 17 | 25 | |
| 18 | 61 | |
| 19 | 21 | |
| 20 | 14 |
About Lei Ni
Lei Ni is a scholar working on Cancer Research, Hepatology and Molecular Biology, having authored 101 papers that have together received 1.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (18 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (485 citations), Immunology (266 citations) and Hepatology (99 citations). Lei Ni has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Li Zuo, Chia‐Chen Chuang, Jianwen Liu, Chen Huang, Jonathan P. Moorman, Xiao Y. Wu, Ke Shen, Jun Cheng, Zhi Q. Yao and Dongdong Tong. Their work appears in journals such as The Journal of Immunology, PLoS ONE and The Science of The Total Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.